Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003133203 | SCV003813604 | likely pathogenic | not provided | 2022-08-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765572 | SCV004579976 | likely pathogenic | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2022-12-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser20712Leufs*3) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 266119). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Diagnostics Division, |
RCV000256437 | SCV000323255 | uncertain significance | Muscular dystrophy | 2016-01-01 | no assertion criteria provided | clinical testing |